Represents costs recorded to Other operating expense, net incurred in connection with the separation of BD's former Diabetes Care business.

- Revenue Adjustment Impact reflects the recognition of accruals resulting from developments relating to the Italian government medical device pay back legislation, as well as another legal matter, ...

- Revenue Adjustment Impact reflects the recognition of accruals resulting from developments relating to the Italian government medical device pay back legislation, as well as another legal matter ...

BD (NYSE: BDX) + plans to close a facility in Caesarea, Israel, by the middle of the year. BD continuously reviews its global manufacturing and supply chain network to optimize operations and ...

Alaris Equity Partners Income Trust (TSX:AD.UN) exemplifies a dividend aristocrat trading down but poised for long-term potential. Its current dividend yield of 7.1% is appealing, particularly for ...